CDISC Inclusion/Exclusion Standardized Coding Project: - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

CDISC Inclusion/Exclusion Standardized Coding Project:

Description:

CDISC Inclusion/Exclusion Standardized Coding Project: ASPIRE: Agreement on Standardized Protocol Inclusion Requirements for Eligibility ASPIRE Project Participants ... – PowerPoint PPT presentation

Number of Views:159
Avg rating:3.0/5.0
Slides: 17
Provided by: jni92
Category:

less

Transcript and Presenter's Notes

Title: CDISC Inclusion/Exclusion Standardized Coding Project:


1
CDISC Inclusion/ExclusionStandardized Coding
Project
  • ASPIRE
  • Agreement on Standardized Protocol Inclusion
    Requirements for Eligibility

2
ASPIRE Project Participants
  • Joyce Niland, Lead City of Hope jniland_at_coh.o
    rg
  • Elly Cohen, Co-Lead UCSF Elly.cohen_at_ucsfmedct
    r.org
  • Greg Eoyang, Admin Lead Digital Infuzion
  • grege_at_digitalinfuzion.com
  • Lakshmi Grama NIH
  • lgrama_at_mail.nih.gov
  • Cortney Hayflinger GSK
    Cortney.d.hayflinger_at_gsk.com
  • Robert Wang ClinTrialStat
  • clintrialstat_at_yahoo.com
  • Jeffrey Suico LLCR
  • suicoje_at_lilly.com
  • Charles Barr Roche Laboratories Inc
    charles_e.barr_at_roche.com

3
The Challenge We FaceStatistics from Oncology
  • According to the research literature
  • Over 1.2 million patients are diagnosed with
    cancer in the U.S. each year
  • Somewhere between 12 and 44 of all
    cancerpatients are eligible for clinical trial
    enrollment
  • Only 1 to 3 of eligible patients
    actuallyparticipate
  • If only 10 of eligible patients participated
    inoncology clinical trials, trials could be
    completedmuch more rapidly than the current 3-5
    years
  • Corresponding increased rates of new
    drugdevelopment and availability

4
Potential Questions to be Answered via
Standardized Coded Eligibility Criteria
  • Patients/Providers/Family Members
  • Does a specific center have an open trial formy
    condition?
  • Investigators
  • Who and where are my potential collaborators and
    competitors?
  • Sponsors
  • Where can I run my new trial so that it
    doesntoverlap with a centers other trials?
  • Centers
  • How can we disseminate information to increase
    and/or expedite patient accrual?

5
Charter Mission of the ASPIRE Subcommittee
  • Charter
  • To serve as a subgroup of the CDISC Protocol
    Representation Committee, charged with developing
    proposed standardized method(s)of encoding
    protocol eligibility criteria, using accepted
    medical terminology and vocabulary standards
  • Mission
  • To facilitate more rapid efficient screening of
    potential participants for available clinical
    trials worldwide, to help speed the discovery of
    new interventions to treat, prevent or screen
    for disease among patients, and to serve as the
    underpinning for various technical
    implementations to facilitate subject screening
    and recruitment

6
Key Deliverable Pan-Disease and Disease-Specific
Coded Core Eligibility Criteria
  • Agreement upon a core set of standardized
    eligibility codes, pan-disease and
    disease-specific, that cut across many studies
  • Not an attempt to fully code or automate full
    inclusion/exclusion criteria for protocols
  • Augments protocol registration data
  • Facilitates disease-specific coded searches to
    filter available protocols based on patients
    presenting characteristics

7
Sample Use Case City of Hope Breast
Cancer-Specific Protocol Search Filter
8
Left Blank
9
(No Transcript)
10
Filled In
11
(No Transcript)
12
Pros/Cons of Disease-Specific Coded Core
Eligibility Criteria
  • Advantages
  • Facile / practical to code new protocols becomes
    part of electronic instantiation of protocol
  • Rapidly enhances patient/provider capability to
    identify potential trials while eliminating
    inappropriate studies, or data mining to ID
    patients (cast wide net, avoid false
    negatives)
  • Disadvantages
  • Doesnt automatically match patient to protocol
    (very difficult to achieve, timing of tests,
    experimental tests, etc.)
  • Requires much work to cover many diseases

13
Activities to Date and Future
  • To Date
  • Submitted as official sub-project with HL7 RCRIM
  • Held numerous conference calls to discuss core
    eligiblity criteria
  • Completed pan-disease criteria, and
    disease-specific criteria for breast cancer and
    diabetes
  • Vetted twice with CDISC Protocol Representation
    Group
  • Harmonized with WHO registry elements, STDM,
    CDASH Pkg. 2 (and BRIDG in future)

14
Activities to Date and Future
  • Future
  • Tackling pediatric hypertension as next disease
    (per CDISC pilot)
  • Joining HL7/OMG Clinical Research Filtered Query
    project to provide sample use case to exercise
    the filter message
  • Conducting an evaluation plan using breast cancer
    criteria
  • Propose to code all breast cancer trials in PDQ
    for core eligibility
  • Requesting permission to utilize NCCN database of
    gt30,000 coded breast cancer patients from last 10
    years
  • Apply filter algorithm to match patients to
    open protocols and determine yield
  • Follow with bootstrapping technique to drop out
    one criterion at a timeand reevaluate protocol
    match yield

15
3 Tiers of Clinical Trial Objects
ProtocolRegistered
Higher RiskProtocol
Available for Accrual
Available for Accrual
ProtocolTier
Conditions met,N slots available
Registration
Consentmodification
N 1slots Available
ConceptApproved
Suggestedfor Protocol
PatientRegistered
FullyEligible
Consented
RXHeld
Study ConductTier
On-Study
.
Treatment Monitoring
AE
Eligibility Screening
ConsentingProcesses
AccessioningProcesses
Eligibility Filtering
Data Tier
ConsentForm
SAEReport
Eligibility Checklist
Form A
City of Hope
16
Questions/Discussion
Write a Comment
User Comments (0)
About PowerShow.com